Interaction of mediators and effector cells in cashew nut-induced anaphylaxis

被引:1
作者
Rontynen, Petteri [1 ,2 ,5 ]
Kukkonen, Kaarina [2 ,3 ,4 ]
Savinko, Terhi [1 ,2 ]
Makela, Mika J. [1 ,2 ]
机构
[1] Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[4] Univ Helsinki, Pediat Res Ctr, Helsinki, Finland
[5] Iho Ja Allergiasairaala, Meilahdentie 2, Helsinki 000290, Finland
关键词
PLATELET-ACTIVATING-FACTOR; EOSINOPHIL CATIONIC PROTEIN; DOUBLE-BLIND; BIOLOGICAL-PROPERTIES; EUROPEAN ACADEMY; FOOD CHALLENGES; TRYPTASE LEVELS; SERUM TRYPTASE; CHILDREN; ALLERGY;
D O I
10.1016/j.anai.2023.04.014
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The underlying mechanisms of an immediate food-induced allergic reaction involve mast cell degranulation and recruitment of other effector cells, such as lymphocytes, eosinophils, and basophils. How the interaction of various mediators and cells results in anaphylaxis is not fully understood. Objective: To evaluate changes in platelet-activating factor (PAF), platelet-activating factor acetylhydrolase (PAF-AH), tryptase, eosinophils, basophils, and eosinophil cationic protein (ECP) in cashew nut-induced anaphylaxis. Methods: Open cashew nut challenges were performed on 106 children (aged 1-16 years), sensitized to cashew nut, with earlier allergic reaction to cashew nut or no known exposure. PAF, PAF-AH, tryptase, ECP, eosinophils, and basophils were measured at 4 time points. Results: Of 72 challenges with positive results, 34 were defined as anaphylactic. Eosinophil count decreased progressively during an anaphylactic reaction at all 4 time points (P < .005*) compared with baseline. Although significant PAF elevation was observed 1 hour from moderate-to-severe reaction (P = .04*), PAF seemed to peak especially in anaphylaxis but did not achieve statistical significance. PAF peak ratio (peak PAF/baseline PAF) was significantly greater in anaphylactic reactions compared with the no-anaphylaxis group (P = .008*). Maximal percentage change in eosinophils revealed negative correlation to severity score and PAF peak ratio (Spearman's rho -0.424 and -0.516, respectively). Basophils decreased significantly in moderate-to-severe reactions and in anaphylaxis (P < .05*) compared with baseline. Delta-tryptase (peak tryptase minus baseline) did not differ significantly between anaphylaxis and the no-anaphylaxis subgroups (P = .05). Conclusion: PAF is a specific anaphylaxis biomarker. Marked decline of eosinophils during anaphylaxis may be related to robust secretion of PAF reflecting migration of eosinophils to target tissues. Copyright (C) 2023 The Authors. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:239 / 252.e6
页数:20
相关论文
共 13 条
  • [1] Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management
    Ducharme, Laurence
    Gabrielli, Sofianne
    Clarke, Ann E.
    Morris, Judy
    Gravel, Jocelyn
    Lim, Rodrick
    Chan, Edmond S.
    Goldman, Ran D.
    O'Keefe, Andrew
    Gerdts, Jennifer
    Chu, Derek K.
    Upton, Julia
    Hochstadter, Elana
    Bretholz, Adam
    McCusker, Christine
    Zhang, Xun
    Ben-Shoshan, Moshe
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (03) : 335 - 341
  • [2] Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond
    Nguyen, Samantha Minh Thy
    Rupprecht, Chase Preston
    Haque, Aaisha
    Pattanaik, Debendra
    Yusin, Joseph
    Krishnaswamy, Guha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [3] Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity
    Hogan, Simon P.
    Wang, Yui Hsi
    Strait, Richard
    Finkelman, Fred D.
    SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (05) : 643 - 653
  • [4] Mediators of the homeostasis and effector functions of memory Th2 cells as novel drug targets in intractable chronic allergic diseases
    Yeon, Seung-min
    Choi, Aryeong
    Hong, Min Soo
    Jung, Yong Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (09) : 754 - 765
  • [5] Mediators of the homeostasis and effector functions of memory Th2 cells as novel drug targets in intractable chronic allergic diseases
    Seung-min Yeon
    Aryeong Choi
    Min Soo Hong
    Yong Woo Jung
    Archives of Pharmacal Research, 2019, 42 : 754 - 765
  • [6] Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice
    Reber, Laurent L.
    Marichal, Thomas
    Mukai, Kaori
    Kita, Yoshihiro
    Tokuoka, Suzumi M.
    Roers, Axel
    Hartmann, Karin
    Karasuyama, Hajime
    Nadeau, Kari C.
    Tsai, Mindy
    Galli, Stephen J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (04) : 881 - +
  • [7] Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma
    Kawakubo, Naonori
    Tanaka, Sakura
    Kinoshita, Yoshiaki
    Tajiri, Tatsuro
    Yonemitsu, Yoshikazu
    Taguchi, Tomoaki
    JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (08) : 1615 - 1620
  • [8] ROLE OF EFFECTOR CELLS (CCR7-CD27-) AND EFFECTOR-MEMORY CELLS (CCR7-CD27+) IN DRUG-INDUCED MACULOPAPULAR EXANTHEMA
    Fernandez, T. D.
    Torres, M. J.
    Lopez, S.
    Antunez, C.
    Gomez, E.
    Del Prado, M. F.
    Canto, G.
    Blanca, M.
    Mayorga, C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (02) : 437 - 447
  • [9] T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice
    Li, Bobby W. S.
    de Bruijn, Marjolein J. W.
    Lukkes, Melanie
    van Nimwegen, Menno
    Bergen, Ingrid M.
    KleinJan, Alex
    GeurtsvanKessel, Corine H.
    Andeweg, Arno
    Rimmelzwaan, Guus F.
    Hendriks, Rudi W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (01) : 144 - 156
  • [10] Stabilization of activated mast cells by ORAI1 inhibitor suppresses peanut-induced anaphylaxis and acute diarrhea
    Suk, Gyeongseo
    Kwon, Do Hoon
    Roers, Axel
    Abraham, Soman N.
    Choi, Hae Woong
    PHARMACOLOGICAL RESEARCH, 2023, 196